Beacon Pointe Advisors, LLC
- SEC CIK
- 0001744317
- Latest filing
- Aug 18, 2026
BTAIQ holding history
BioXcel Therapeutics, Inc. in every 13F filed by Beacon Pointe Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
BTAIQ overviewAll 13F holders of BTAIQFull Q2 2026 holdings
- Shares (Q2 2026)
- 18,837
- Value
- $26.6K
- % of portfolio
- <0.1%
- Quarters held
- 8
- Since Q4 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 18,837 | $26.6K | <0.1% | −40−0.2% | Reduced | Holders |
| Q1 2026 | 18,877 | $25.3K | <0.1% | +18,877 | New | Holders |
| Q3 2025 | 0 | $0 | 0.0% | −18,845−100.0% | Sold out | Holders |
| Q2 2025 | 18,845 | $34.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 18,845 | $38.3K | <0.1% | +18,845 | New | Holders |
| Q2 2024 | 0 | $0 | 0.0% | −301,735−100.0% | Sold out | Holders |
| Q1 2024 | 301,735 | $850.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 301,735 | $890.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 301,735 | $763.4K | <0.1% | +301,735 | New | Holders |
| Q1 2023 | 0 | $0 | 0.0% | −302,150−100.0% | Sold out | Holders |
| Q4 2022 | 302,150 | $6.49M | 0.1% | +302,150 | New | Holders |